This article is available to subscribers. Subscribe now. Already have an account? Sign in

Review ArticleFree Preview


List of authors.
  • Laura A. Magee, M.D.,
  • Kypros H. Nicolaides, M.D.,
  • and Peter von Dadelszen, D.Phil.

Preeclampsia complicates 2 to 4% of all pregnancies and accounts for about 46,000 maternal deaths and 500,000 fetal or newborn deaths each year. Antihypertensive agents and magnesium sulfate can help control the systemic manifestations of preeclampsia, which is usually resolved by delivery of the placenta.

Continue reading this article

Select an option below:

Create your account to get 2 free subscriber-only articles each month.

Get Free Access Now Subscribe For Full Access

Already have an account?

Sign In

Print subscriber?

Activate your online access.

Funding and Disclosures

Disclosure forms provided by the authors are available with the full text of this article at

Author Affiliations

From the Department of Women and Children’s Health, School of Life Course Sciences, King’s College London (L.A.M., K.H.N., P.D.), the Institute of Women and Children’s Health, King’s Health Partners Academic Health Science Centre (L.A.M., P.D.), and the Harris Birthright Research Centre for Fetal Medicine, King’s College Hospital (K.H.N.) — all in London.

Dr. Magee can be contacted at or at King’s College London, 6th Floor, Addison House Guy’s Campus, Great Maze Pond, London SE1 1UL, United Kingdom.

Print Subscriber? Activate your online access.